MicroRNA-103a inhibits gastric cancer cell proliferation, migration and invasion by targeting c-Myb

Cell Proliferation

Volumn 48, Issue 1, 2015, Pages 78-85

  Liang, Jinlong ^a   Liu, Xianfeng ^b   Xue, Hongpeng ^a   Qiu, Bing ^a   Wei, Bin ^b   Sun, Kan ^a  

^a Key Laboratory of Remote Sensing Monitoring of Geographic Environment   (China)

^b General Hospital of Daqing Oil Field   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 103A; UNCLASSIFIED DRUG; MIRN103 MICRORNA, HUMAN; PROTEIN C MYB;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GASTRIC CANCER CELL LINE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CARCINOGENESIS; TUMOR SUPPRESSOR GENE; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; STOMACH TUMOR; TUMOR CELL LINE; TUMOR INVASION;

CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; PROTO-ONCOGENE PROTEINS C-MYB; STOMACH NEOPLASMS;

EID: 84920876822     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/cpr.12159     Document Type: Article

References (32)

1. Yasui W, Sentani K, Sakamoto N, Anami K, Naito Y, Oue N (2011) Molecular pathology of gastric cancer: research and practice. Pathol. Res. Pract. 207, 608-612.
2. Gigek CO, Chen ES, Calcagno DQ, Wisnieski F, Burbano RR, Smith MA (2012) Epigenetic mechanisms in gastric cancer. Epigenomics 4, 279-294.
3. Leja M, Wex T, Malfertheiner P (2012) Markers for gastric cancer premalignant lesions: where do we go? Dig. Dis. 30, 268-276.
4. Thiel A, Ristimaki A (2012) Gastric cancer: basic aspects. Helicobacter 17(Suppl 1), 26-29.
5. Yao Y, Suo AL, Li ZF, Liu LY, Tian T, Ni L et al. (2009) MicroRNA profiling of human gastric cancer. Mol. Med. Rep. 2, 963-970.
6. Bonazzi VF, Stark MS, Hayward NK (2012) MicroRNA regulation of melanoma progression. Melanoma Res. 22, 101-113.
7. Martello G, Rosato A, Ferrari F, Manfrin A, Cordenonsi M, Dupont S et al. (2010) A MicroRNA targeting dicer for metastasis control. Cell 141, 1195-1207.
8. Mo YY (2012) MicroRNA regulatory networks and human disease. Cell. Mol. Life Sci. 69, 3529-3531.
9. Cheng H, Shi S, Cai X, Long J, Xu J, Liu C et al. (2012) microRNA signature for human pancreatic cancer invasion and metastasis. Exp. Ther. Med. 4, 181-187.
10. Jansson MD, Lund AH (2012) MicroRNA and cancer. Mol. Oncol. 6, 590-610.
11. Agirre X, Vilas-Zornoza A, Jimenez-Velasco A, Martin-Subero JI, Cordeu L, Garate L et al. (2009) Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia. Cancer Res. 69, 4443-4453.
12. Ibrahim SA, Yip GW, Stock C, Pan JW, Neubauer C, Poeter M et al. (2012) Targeting of syndecan-1 by microRNA miR-10b promotes breast cancer cell motility and invasiveness via a Rho-GTPase- and E-cadherin-dependent mechanism. Int. J. Cancer 131, E884-E896.
13. Ladeiro Y, Couchy G, Balabaud C, Bioulac-Sage P, Pelletier L, Rebouissou S et al. (2008) MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology 47, 1955-1963.
14. Patnaik SK, Kannisto E, Knudsen S, Yendamuri S (2010) Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection. Cancer Res. 70, 36-45.
15. Sarver AL, French AJ, Borralho PM, Thayanithy V, Oberg AL, Silverstein KA et al. (2009) Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. BMC Cancer 9, 401.
16. Vaira V, Faversani A, Dohi T, Montorsi M, Augello C, Gatti S et al. (2012) miR-296 regulation of a cell polarity-cell plasticity module controls tumor progression. Oncogene 31, 27-38.
17. Chen HY, Lin YM, Chung HC, Lang YD, Lin CJ, Huang J et al. (2012) miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4. Cancer Res. 72, 3631-3641.
18. Yu D, Zhou H, Xun Q, Xu X, Ling J, Hu Y (2012) microRNA-103 regulates the growth and invasion of endometrial cancer cells through the downregulation of tissue inhibitor of metalloproteinase 3. Oncol. Lett. 3, 1221-1226.
19. Tchernitsa O, Kasajima A, Schafer R, Kuban RJ, Ungethum U, Gyorffy B et al. (2010) Systematic evaluation of the miRNA-ome and its downstream effects on mRNA expression identifies gastric cancer progression. J. Pathol. 222, 310-319.
20. Li X, Zhang Y, Zhang H, Liu X, Gong T, Li M et al. (2011) miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. Mol. Cancer Res. 9, 824-833.
21. Wisnieski F, Calcagno DQ, Leal MF, dos Santos LC, Gigek Cde O, Chen ES et al. (2013) Reference genes for quantitative RT-PCR data in gastric tissues and cell lines. World J. Gastroenterol. 19, 7121-7128.
22. Li Z, Shen J, Wu WK, Yu X, Liang J, Qiu G et al. (2012) Leptin induces cyclin D1 expression and proliferation of human nucleus pulposus cells via JAK/STAT, PI3K/Akt and MEK/ERK pathways. PLoS One 7, e53176.
23. Xu J, Kang Y, Liao WM, Yu L (2012) MiR-194 regulates chondrogenic differentiation of human adipose-derived stem cells by targeting Sox5. PLoS One 7, e31861.
24. Wu WK, Lee CW, Cho CH, Fan D, Wu K, Yu J et al. (2010) MicroRNA dysregulation in gastric cancer: a new player enters the game. Oncogene 29, 5761-5771.
25. Shrestha S, Hsu SD, Huang WY, Huang HY, Chen W, Weng SL et al. (2014) A systematic review of microRNA expression profiling studies in human gastric cancer. Cancer Med. 3, 878-888.
26. Cai W, Li Q, Yang Z, Miao X, Wen Y, Huang S et al. (2013) Expression of p53 upregulated modulator of apoptosis (PUMA) and C-myb in gallbladder adenocarcinoma and their pathological significance. Clin. Transl. Oncol. 15, 818-824.
27. Chen RX, Xia YH, Xue TC, Ye SL (2010) Transcription factor c-Myb promotes the invasion of hepatocellular carcinoma cells via increasing osteopontin expression. J. Exp. Clin. Cancer Res. 29, 172.
28. Lu H, Wang Y, Huang Y, Shi H, Xue Q, Yang S et al. (2013) Expression and prognostic role of c-Myb as a novel cell cycle protein in esophageal squamous cell carcinoma. Clin. Transl. Oncol. 15, 796-801.
29. Yang H, Huang ZZ, Wang J, Lu SC (2001) The role of c-Myb and Sp1 in the up-regulation of methionine adenosyltransferase 2A gene expression in human hepatocellular carcinoma. FASEB J. 15, 1507-1516.
30. Claerhout S, Lim JY, Choi W, Park YY, Kim K, Kim SB et al. (2011) Gene expression signature analysis identifies vorinostat as a candidate therapy for gastric cancer. PLoS One 6, e24662.
31. Feng MY, Wang K, Shi QT, Yu XW, Geng JS (2009) Gene expression profiling in TWIST-depleted gastric cancer cells. Anat. Rec. (Hoboken) 292, 262-270.
32. Ramsay RG, Thompson MA, Hayman JA, Reid G, Gonda TJ, Whitehead RH (1992) Myb expression is higher in malignant human colonic carcinoma and premalignant adenomatous polyps than in normal mucosa. Cell Growth Differ. 3, 723-730.